Sort
82,697 grants matching “vaccine development”
Continued Development of a Recombinant Vaccine (RivaxTM) against Ricin Toxin
$687,326Robert Newton Brey · Soligenix, Inc. · U01 · FY2008 · AI
Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesis
$687,322Michael A Barry · Mayo Clinic Rochester · R01 · FY2022 · AI
Career Development and Training Program
$687,296David H Walker · University Of Texas Med Br Galveston · U54 · FY2010 · AI
Dissecting the role of the Inclusion membrane protein IncE, a master multi-tasking scaffolding protein, in the pathogenesis of Chlamydia trachomatis infections
$687,224Joanne N. Engel · University Of California, San Francisco · R01 · FY2022 · AI
Developmental Projects
$687,178W. Ian Lipkin · Wadsworth Center · U54 · FY2008 · AI
HIV Protective Immunity and Perinatal Exposure
$687,174Columbia University Health Sciences · R01 · FY2002 · HD
Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic Immunity
$687,168Martin S Zand · University Of Rochester · R01 · FY2020 · AI
Neisserial porins and antigen presenting cells
$687,162Lee Mark Wetzler · Boston Medical Center · R01 · FY2017 · AI
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
$687,160Luc Teyton · Scripps Research Institute, The · U01 · FY2024 · AI
Nipah virus and Hendra virus Peptide Therapeutics
$687,159Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2005 · AI
Chlamydial Immunity and Vaccine Development
$687,147Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Elicitation of broad immunity using VLPs with consensus envs
$687,125Ted M Ross · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · AI
Project 1. Nanolipoprotein-supported multi-subunit vaccine for Chlamydia trachomatis
$687,086Matthew Adrian Coleman · University Of Calif-Lawrnc Lvrmr Nat Lab · U19 · FY2021 · AI
St. Jude-Memphis Adolescent Trials Unit
$687,075Aditya H Gaur · St. Jude Children'S Research Hospital · U01 · FY2012 · HD
Diversity of TFH cells and DSA generation after kidney transplantation
$687,036Diana M Metes · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Natural killer cell regulation of the germinal center HIV neutralizing antibody response
$687,036Todd Christopher Bradley · Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2021 · AI
Tuberculosis and T cell Recognition
$687,018Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$686,990Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · AI
Development Of A Vaccine For Leishmania Major Infection
$686,986Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Development of Pre-Erythrocytic Malaria Vaccines
$686,983Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Baltimore Pediatric AIDS Clinical Trials Group
$686,965Johns Hopkins University · U01 · FY2004 · AI
The role of γδ T cells in fetal and infant immune defense against malaria
$686,871Margaret E Feeney · University Of California, San Francisco · R01 · FY2023 · AI
Synergistic effects of HIV and age on naive CD4+ T-cell senescence
$686,841Beth D. Jamieson-Karavodin · University Of California Los Angeles · R01 · FY2012 · AG
GLYCOSYLATION MUTANTS OF LEISHMANIA
$686,835Stephen M Beverley · Washington University · R01 · FY2007 · AI
Structural and functional characterization of T and NK cell receptors
$686,813Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI